You just read:

CytRx Announces Initial Results of Phase 3 Trial of Aldoxorubicin in Patients with Second-Line Soft Tissue Sarcoma; Subsequent Analysis to Be Announced Fourth Quarter 2016

News provided by

CytRx Corporation

Jul 11, 2016, 16:03 ET